semaglutide heart attack VisualAbstract: improves symptoms in patients with failure Wegovy shown to reduce risk

In many cases, individuals considered for Semaglutide therapy are those who have been diagnosed with obesity or overweight and have struggled to achieve significant weight loss through diet and exercise alone

thelancet.com/journals/lance LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial @TheLancet @LillyTrials #Retatrutide thelancet.com/journals/lance LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial @TheLancet @LillyTrials #Retatrutide Excelente

Most guidelines still recommend discontinuing metformin when eGFR falls below 30 mL/min/1.73 m, despite limited evidence supporting this threshold (Yang et al eClin Med 2024)

The American Journal of Clinical Nutrition, 103(3), 738 to 746

1,16 There are two main types of BPPV: posterior semicircular canal BPPV (also known as posterior canal BPPV) and horizontal semicircular canal BPPV (or horizontal canal BPPV)